15Jul 2026
Experimental Drug Trial for Bundibugyo Ebola Virusa
EXPERIMENTAL DRUG TRIAL FOR BUNDIBUGYO EBOLA VIRUS Why in the News? Clinical Trial: The Democratic Republic of Congo (DRC) has launched a clinical trial to evaluate Gilead Sciences’ experimental antiviral drug Obeldesivir as a post-exposure treatment for the ongoing Bundibugyo Ebola virus outbreak in Congo and Uganda. Research Initiative: The study seeks to determine whether …
Read More
